P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

December 2010

Features

Personalized Medicine

Part 3: Challenges Facing Health Care Plans in Implementing Coverage Policies for Pharmacogenomic and Genetic Testing

The final part of this series covers the usefulness of genetic testing, trends in insurance underwriting, and the anticipated pipeline for new biologics.
F. Randy Vogenberg, PhD, RPh; Carol Isaacson Barash, PhD; and Michael Pursel, RPh, MBA

Efficacy and Safety of a Lower-Dose Valganciclovir (Valcyte) Regimen for Cytomegalovirus Prophylaxis In Kidney and Pancreas Transplant Recipients

Using a lower dose of valganciclovir, at 450 mg daily for six months instead of the recommended 900-mg daily dose, can be efficacious for patients and less expensive for hospitals. The result: reduced drug costs and fewer cases of leukopenia.
Vrinda Bhat, PharmD, Megan McIntyre, PharmD, and Tracey Meyers, PharmD

The Burden of Psoriatic Arthritis

A Literature Review from a Global Health Systems Perspective

Although the burden of psoriatic arthritis has been described extensively in the literature, the burden of illness associated with PsA has not been as well qualified. The authors discuss the substantial economic and quality-of-life costs to patients and society.
Seina Lee, PharmD, MS; Alan Mendelsohn, MD; and Evelyn Sarnes, PharmD, MPH

Pharmaceutical Approval Update

Topics include onabotulinumtoxinA (Botox) for migraine; dabigatran (Pradaxa) for reducing stroke and embolism risk; and lurasidone (Latuda) for schizophrenia.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

American Academy of Physical Medicine and Rehabilitation, 71st Annual Assembly

Selected sessions focused on incobotulinumtoxinA (Xeomin) for focal dystonias.
Walter Alexander

Season's Greetings

Thanks to Our Readers and Reviewers

Departments

Editorial

Isabel, a New Diagnostic Aid for the 21st Century

Isabel, a Web-based checklist system, could become a valuable aid to clinicians in reducing the number of incorrect diagnoses.
David B. Nash, MD, MBA

Medication Errors

Inappropriate Prescribing of Fentanyl Patches Is Still Causing Alarming Safety Problems

Despite earlier precautions from drug companies and the FDA, health care professionals are still prescribing fentanyl patches inappropriately.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Controversy Looms Over Medicare’s New Policy on 'Intentional Overfill' of Injectables

Hospitals Say Curtailed Payments Shouldn’t Apply to Them

The Centers for Medicare and Medicaid Services needs to clarify its new reimbursement rules for "intentional overfill" of injectable drugs.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Drug Forecast

Dalfampridine (Ampyra)

An Aid to Walking in Patients with Multiple Sclerosis

Raymond Lamore III, PharmD Candidate, Elsen Jacob, PharmD Candidate, Susan C. Jacob, PharmD Candidate, and Olga Hilas, PharmD, MPH, BCPS, CGP